The EMCDDA's cooperates with Kyrgyzstan in the framework of the Central Asian Drug Action Programme (CADAP), which is currently in its sixth phase. CADAP 6 reflects the EU’s long-term engagement with Central Asian partners to help further strengthen their national policies in drug demand reduction.